Back
Aligos Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$43.62
Seasonality Move:
7.18%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.61 | Buy |
| 20-day SMA: | 32.22 | Buy |
| 50-day SMA: | 20.6 | Buy |
| 200-day SMA: | 16.51 | Buy |
| 8-day EMA: | 38.12 | Buy |
| 20-day EMA: | 32.66 | Buy |
| 50-day EMA: | 24.43 | Buy |
| 200-day EMA: | 18.11 | Buy |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.71 | Buy |
| Relative Strength Index (14 RSI): | 81.52 | Buy |
| Chaikin Money Flow: | 630913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.74 - 36.8) | Buy |
| Bollinger Bands (100): | (6.83 - 25.23) | Buy |
Aligos Therapeutics Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 43.37 while ALGS 8-day simple moving average is 37.61, which is a Buy signal.
-
The stock price of ALGS is 43.37 while Aligos Therapeutics 20-day SMA is 32.22, which makes it a Buy.
-
Aligos Therapeutics 50-day simple moving average is 20.60 while ALGS share price is 43.37, making it a Buy technically.
-
ALGS stock price is 43.37 and Aligos Therapeutics 200-day simple moving average is 16.51, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a BuyThe current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
155.6M
Price in USD:
43.37
Share Volume:
784.9K
Aligos Therapeutics 52-Week Range
52-Week High:
43.94
52-Week Low:
6.76
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?The Aligos Therapeutics stock price is 43.37 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is not overvalued.
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 43.37 while ALGS 8-day exponential moving average is 38.12, which is a Buy signal.
-
The stock price of ALGS is 43.37 while Aligos Therapeutics 20-day EMA is 32.66, which makes it a Buy.
-
Aligos Therapeutics 50-day exponential moving average is 24.43 while ALGS share price is 43.37, making it a Buy technically.
-
ALGS stock price is 43.37 and Aligos Therapeutics 200-day simple moving average is 18.11, creating a Buy signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is 5.71, suggesting Aligos Therapeutics is a Buy
-
Aligos Therapeutics Relative Strength Index (RSI) is 81.52, which suggest Aligos Therapeutics is overbought
-
The Bollinger Bands (25) for Aligos Therapeutics is (22.74 - 36.8), which suggest Aligos Therapeutics is a Buy
-
The Bollinger Bands (100) for Aligos Therapeutics is (6.83 - 25.23), which suggest Aligos Therapeutics is a Buy
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.